FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
1-Year Return
33.17%
This Quarter Return
+22.3%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$455M
AUM Growth
+$90.7M
(+25%)
Cap. Flow
+$43.9M
Cap. Flow
% of AUM
9.65%
Top 10 Holdings %
Top 10 Hldgs %
56.91%
Holding
55
New
3
Increased
34
Reduced
5
Closed
3
Top Buys
| 1 |
Tandem Diabetes Care
TNDM
|
$23.5M |
| 2 |
SHPG
Shire pic
SHPG
|
$15M |
| 3 |
NeoGenomics
NEO
|
$7.45M |
| 4 |
NVTR
Nuvectra Corporation Common Stock
NVTR
|
$5.39M |
| 5 |
Harvard Bioscience
HBIO
|
$4.01M |
Top Sells
| 1 |
ENTL
Entellus Medical, Inc. Common Stock
ENTL
|
$16.4M |
| 2 |
Nektar Therapeutics
NKTR
|
$5.49M |
| 3 |
QuidelOrtho
QDEL
|
$2.27M |
| 4 |
BLUE
bluebird bio
BLUE
|
$2.12M |
| 5 |
Codexis
CDXS
|
$1.88M |
Sector Composition
| 1 | Healthcare | 84.88% |
| 2 | Communication Services | 4.24% |
| 3 | Energy | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sanofi
SNY
$111B
| $269K | 0.06% |
6,720
| – | – |
|
52
Merck
MRK
$210B
| $234K | 0.05% |
4,500
| – | – |
|
53
MacroGenics
MGNX
$123M
| – | – |
-73,558
| Closed | -$1.4M |
|
54
SPDR S&P Biotech ETF
XBI
$5.28B
| – | – |
-9,499
| Closed | -$806K |
|
|
ENTL
55
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| – | – |
-670,904
| Closed | -$16.4M |
|